前列腺癌高剂量大分割放射治疗研究进展

Advances in hypofractionated-high-dose radiotherapy for prostate cancer

前列腺癌是常见的男性恶性肿瘤之一,在我国,其发病率和死亡率呈逐年上升趋势。随着精确放疗技术的飞速发展,外照射放疗已成为局限期前列腺癌的根治性手段之一。由于前列腺癌特殊的组织学特点,大分割放疗越来越多地应用于临床。本文就前列腺癌大分割剂量根治性放疗的研究进展做一综述。

Prostate cancer （PC） is a common male malignant tumor with increasing morbidity and mortality in China. With the development of technologies of accurate radiotherapy, external beam radiation therapy （EBRT） has become one of the radical therapeutic methods for localized PC. Due to the special biological characteristics of PC, hypofractionated-high-dose radiotherapy can achieve better therapeutic results in clinic. The current state of hypofractionated-high-dose radiotherapy in PC is summarized in this review.